SkinHealth Systems Inc.

SkinHealth Systems Inc.

0.48
EUR
0.00
(0.00%)
-3.86EPS
80.01MMarket Cap
Nov 10Next Earn

Total Valuation

EUR

As of June 30, 2026, SkinHealth Systems Inc. Class A carries a market capitalization of 80.01M, placing it among publicly traded companies globally. Its enterprise value stands at 220.91M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap80.01M
Enterprise Value220.91M

Important Dates

SkinHealth Systems Inc. Class A's next confirmed earnings release is scheduled for November 10, 2026.

Earnings Date11/10/2026

Share Statistics

As of June 30, 2026, SkinHealth Systems Inc. Class A has 6.51M shares outstanding.

Shares Outstanding6.51M

Valuation Ratios

These figures are as of June 30, 2026. The price-to-sales ratio is 0.31, and the price-to-book ratio stands at 1.65.

PS Ratio0.31
PB Ratio1.65
P/TBV Ratio-0.91
P/FCF Ratio5.44
P/OCF Ratio4.09

Enterprise Valuation

As of June 30, 2026, SkinHealth Systems Inc. Class A trades at an EV/EBITDA multiple of 12.57 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.87 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 220.91M versus a market cap of 80.01M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales0.87
EV / EBITDA12.57

Financial Position

As of June 30, 2026, SkinHealth Systems Inc. Class A maintains a current ratio of 1.76, meaning it holds 1.8x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 660.53, indicating elevated leverage, while an interest coverage ratio of 0.79 demonstrates limited ability to service its debt obligations.

Current Ratio1.76
Quick Ratio1.34
Debt / Equity660.53
Debt / EBITDA18.28
Interest Coverage0.79

Financial Efficiency

EUR

Over the twelve months ended June 30, 2026, SkinHealth Systems Inc. Class A posted a negative return on equity (ROE) of -43.89, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -5.72, reflecting losses generated across the asset base. The company generates approximately 389,382.31 in revenue per employee across its workforce of 652.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 1.84 indicates how many times SkinHealth Systems Inc. Class A sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-43.89
Return on Assets (ROA)-5.72
Revenue Per Employee389,382.31
Employee Count652.00
Inventory Turnover1.84

Taxes

EUR

Over the twelve months ended June 30, 2026, SkinHealth Systems Inc. Class A recorded 4.12M in income tax expense. The company reported a pretax loss of -20.77M and -24.89M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax4.12M

Stock Price Statistics

EUR

As of the close on October 12, 2026, SkinHealth Systems Inc. Class A's stock has declined approximately 61.76% over the past 52 weeks. The 50-day moving average sits at 0.57, while the 200-day moving average is 0.77.

52-Week Price Change-61.76%
50-Day Moving Average0.57
200-Day Moving Average0.77

Income Statement

EUR

Over the twelve months ended June 30, 2026, SkinHealth Systems Inc. Class A generated 253.88M in revenue and converted that into -24.89M in net income, yielding earnings per share of -3.86. EBITDA reached 17.58M, while operating income came in at -3.77M.

Revenue253.88M
Gross Profit168.45M
Operating Income-3.77M
Pretax Income-20.77M
Net Income-24.89M
EBITDA17.58M
EBIT-3.77M
Earnings Per Share (EPS)-3.86

Balance Sheet

EUR

As of June 30, 2026, SkinHealth Systems Inc. Class A holds 180.38M in cash and equivalents against 321.27M in total debt, resulting in a net debt position of 121.78M. Total book value stands at 48.64M, with working capital of 111.20M providing operational flexibility.

Cash & Cash Equivalents180.38M
Total Debt321.27M
Net Debt121.78M
Equity (Book Value)48.64M
Book Value Per Share7.48
Working Capital111.20M

Cash Flow

EUR

SkinHealth Systems Inc. Class A produced 19.22M in operating cash flow over the twelve months ended June 30, 2026. After subtracting -4.66M in capital expenditures, free cash flow totaled 14.56M - equivalent to 2.28 per share.

Operating Cash Flow19.22M
Capital Expenditures-4.66M
Free Cash Flow14.56M
FCF Per Share2.28

Margins

Over the twelve months ended June 30, 2026, SkinHealth Systems Inc. Class A posted a gross margin of 66.35, reflecting its pricing power and cost economics. The operating margin of -1.49 and net profit margin of -9.80 provide insight into operational efficiency.

Gross Margin66.35
Operating Margin-1.49
Pretax Margin-8.18
Profit Margin-9.80
EBITDA Margin6.92

Dividends & Yields

These figures cover the twelve months ended June 30, 2026. Free cash flow yield stands at 18.38, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 24.55, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to SkinHealth Systems Inc. Class A shareholders.

Shareholder Yield24.55
FCF Yield18.38

Stock Splits

SkinHealth Systems Inc. Class A's most recent stock split took place on October 14, 2026 with a 20:1 split ratio.

Last Split Date10/14/2026
Split Ratio20:1

Scores

As of June 30, 2026, SkinHealth Systems Inc. Class A has an Altman Z-Score of -0.81, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-0.81